Screener
Lifecore Biomedical, Inc. LFCR Cost of Goods Sold
Cost of Goods Sold at other companies
Other financials
Where this comes from
Reported directly by Lifecore Biomedical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The source filing: Lifecore Biomedical, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 7:20 AM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q3 2026
- Accession
- 0001005286-26-000033
| (in thousands, except share and per share amounts) | Three months ended / June 30,2026 | Three months ended / May 25,2025 | Six months ended / June 30,2026 | Six months ended / May 25,2025 |
|---|---|---|---|---|
| Revenues | $11,480 | $19,768 | $25,716 | $36,001 |
| Revenues, related party | 22,687 | 16,676 | 31,644 | 35,597 |
| Total revenues | 34,167 | 36,444 | 57,360 | 71,598 |
| Cost of sales | 22,092 | 22,462 | 40,823 | 47,771 |
| Gross profit | 12,075 | 13,982 | 16,537 | 23,827 |
| Research and development expenses | 1,537 | 2,103 | 2,754 | 4,148 |
| Selling, general, and administrative expenses | 7,971 | 8,980 | 15,888 | 19,073 |
| Restructuring recovery | — | (2,519) | — | (2,634) |
Item 1. Financial
FAQ
- What is Lifecore Biomedical, Inc.'s cost of goods sold?
- Lifecore Biomedical, Inc. (LFCR) reported cost of goods sold of $22.09M in Q2 2026.
- What is the long-term trend for Lifecore Biomedical, Inc.'s cost of goods sold?
- Over 3 years (2022 to 2025), Lifecore Biomedical, Inc.'s cost of goods sold has grown at a 9.1% compound annual growth rate (CAGR), from $68.22M to $88.57M.
- What does cost of goods sold mean?
- Cost Of Goods And Services Sold as reported by Lifecore Biomedical, Inc. Common Stock.
Ask your AI about Lifecore Biomedical, Inc.'s cost of goods sold.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude